These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15772984)

  • 1. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
    Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
    J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrafollicular proliferation of B cells in the absence of follicular hyperplasia: a distinct reaction pattern in lymph nodes correlated with primary or recall type responses.
    Brighenti A; Andrulis M; Geissinger E; Roth S; Müller-Hermelink HK; Rüdiger T
    Histopathology; 2005 Jul; 47(1):90-100. PubMed ID: 15982328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
    Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
    Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
    Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
    J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
    Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
    Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
    White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
    J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
    Carbone A; Gloghini A; Gaidano G
    Int J Biol Markers; 1999; 14(3):144-8. PubMed ID: 10569135
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
    King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
    Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype.
    Usui T; Wakatsuki Y; Matsunaga Y; Kaneko S; Koseki H; Kita T
    J Immunol; 1997 Apr; 158(7):3197-204. PubMed ID: 9120274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
    Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
    Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas.
    Bai M; Panoulas V; Papoudou-Bai A; Horianopoulos N; Kitsoulis P; Stefanaki K; Rontogianni D; Agnantis NJ; Kanavaros P
    Leuk Lymphoma; 2006 Mar; 47(3):495-501. PubMed ID: 16396774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.
    Adams H; Liebisch P; Schmid P; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):96-101. PubMed ID: 18838917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.
    Costes V; Magen V; Legouffe E; Durand L; Baldet P; Rossi JF; Klein B; Brochier J
    Hum Pathol; 1999 Dec; 30(12):1405-11. PubMed ID: 10667416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.
    Torlakovic E; Torlakovic G; Nguyen PL; Brunning RD; Delabie J
    Am J Surg Pathol; 2002 Oct; 26(10):1343-50. PubMed ID: 12360049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
    Nie K; Gomez M; Landgraf P; Garcia JF; Liu Y; Tan LH; Chadburn A; Tuschl T; Knowles DM; Tam W
    Am J Pathol; 2008 Jul; 173(1):242-52. PubMed ID: 18583325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.